I received the following alert out of Minnesota:
This is a reminder that the Minnesota Medical Cannabis Program will be holding its second New Condition Review Panel Meeting on Tuesday, September 26, 2017. During this meeting, the panel members will be reviewing five of the ten petitioned conditions: liver disease, anxiety, obstructive sleep apnea, endocannabinoid deficiency, and dementia.
When: Tuesday, September 26, 2017, 1-4 p.m.
Where: State Office Building
100 Rev Dr. Martin Luther King Jr. Blvd
St. Paul, MN 55155
This meeting is open to the public. Public testimony will be available following the review of the petitioned conditions.
If you are unable to attend and would like to participate, written comments regarding the potential risks or potential benefits of adding any of the petitioned medical conditions can be sent to [email protected]
Marijuana Policy Project